Alka-seltzer Original
NDC Package 65662-005-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Alka-seltzer Original is directionsfully dissove 2 tablets in 4 ounces of water before takingadults and children 12 years and over2 tablets every 4 hours, or as directed by a doctordo not exceed 8 tablets in 24 hoursadults 60 years and over2 tablets every 4 hours, or as directed by a doctordo not exceed 4 tablets in 24 hourschildren under 12 yearsconsult a doctor. Marketed by Bayer Bitterfeld Gmbh, this product is identified by NDC 65662-005 and is authorized under FDA application part343.

Identification & Billing

NDC Package Code
65662-005-01
Package Description
6 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH
Product Code
65662-005
11-Digit Billing Format
65662000501
RxNorm Crosswalk
  • RxCUI: 1536675 - aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG Effervescent Oral Tablet
  • RxCUI: 1536675 - ASA 325 MG / Citric Acid 1000 MG / NaHCO3 1916 MG Effervescent Oral Tablet
  • RxCUI: 1536680 - Alka-Seltzer 325 MG / 1000 MG / 1916 MG Effervescent Oral Tablet
  • RxCUI: 1536680 - aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG Effervescent Oral Tablet [Alka-Seltzer]
  • RxCUI: 1536680 - Alka-Seltzer (aspirin 325 MG / citric acid 1000 MG / sodium bicarbonate 1916 MG) Effervescent Oral Tablet

Clinical Specifications

Proprietary Name
Alka-seltzer Original
Dosage Form
-
Usage Information
Directionsfully dissove 2 tablets in 4 ounces of water before takingadults and children 12 years and over2 tablets every 4 hours, or as directed by a doctordo not exceed 8 tablets in 24 hoursadults 60 years and over2 tablets every 4 hours, or as directed by a doctordo not exceed 4 tablets in 24 hourschildren under 12 yearsconsult a doctor

Regulatory & Marketing

Labeler Name
Bayer Bitterfeld Gmbh
FDA Application #
part343
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
12-01-2008
Listing Expiration
12-31-2020
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 65662-005-01 identifies a specific commercial package of 6 pouch in 1 carton / 2 tablet, effervescent in 1 pouch of Alka-seltzer Original, labeled by Bayer Bitterfeld Gmbh. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Bayer Bitterfeld Gmbh on December 01, 2008. The current certification is valid through December 31, 2020.

How is this Bayer Bitterfeld Gmbh product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 65662000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
65662-005-01
11-Digit CMS (5-4-2)
65662-0005-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.